Stock News

A Leading HIV Drug Is Way Overpriced in the U.S.
Gilead- A Top Biotech for Turnaround Investors
Lawsuit accuses Gilead of propping up cost of lifesaving HIV treatments by blocking generic competition
Market Morning: Kudlow Cracks, Brexiters Rage, Gilead Butters Up FDA, Philip Morris Backtracks

As seen on...